4.6 Review

Strategies for the identification, control and determination of genotoxic impurities in drug substances: A pharmaceutical industry perspective

Journal

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Volume 55, Issue 4, Pages 662-667

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jpba.2010.11.039

Keywords

Identification; Control; Genotoxic impurities; Drug substances; Pharmaceutical industry

Ask authors/readers for more resources

Regulations alarmed the control of genotoxic impurities in drug substances at lower level based on the threshold of toxicological concern and daily dose. This review explores the details of various regulations and guidances, toxicology assessment, identification of structural alerts, synthetic origins, different synthetic approaches for elimination or control, various analytical determination strategies and pharmaceutical industry concern towards genotoxic impurities. (C) 2010 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available